glp 1 reducing inflammation Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology GLP-1 drugs protect brain health

A pre-treatment electrolyte panel identifies any existing imbalances before the medication is added to the picture

The potential side-effects of GLP-1 medication have attracted attention

GLP-1 agonists suppress appetite through peripheral gut hormone signaling and central satiety pathways

These symptoms may be worse after fatty meals, which require the release of more bile

"From a maintenance and weight loss standpoint, many of our patients are interested in trying to understand what they need to eat long term and what their new dietary pattern may look like

Rare but serious events such as pancreatitis (inflammation of the pancreas) or medullary thyroid cancer remain under surveillance because of animal toxicity signals